Most adults who meet the criteria for substance use disorder began their use in their teenage or young adult years. For this reason, early and effective substance use prevention for youth is extremely important. “Effective” is a key word when it comes to youth substance use prevention efforts. For years, Project Drug Abuse Resistance Education […]
Evidence-Based and Best Practices
For 23 years, IRETA has hosted medical students for the Scaife Medical Student Fellowship in Substance Use Disorders. The program has been held virtually since 2020, due to COVID-19. This year’s program continued online. For three weeks in both June and July, small cohorts of medical and pharmacy students logged in from across the country […]
Is a Juul ban enough to solve the problem of nicotine addiction in young adults? Time has shown us that bans often don’t keep people from using a product or substance.
Despite that fact that transgender and gender non-conforming people disproportionately experience substance use and mental health disorders, there is a lack of trans-inclusive care and knowledge about gender identity within the addiction treatment field.
Much of the recent discourse in the addiction treatment and recovery community has touched upon the record-breaking rise in overdose deaths in the United States, as well as the sharp uptick in alcohol use that came about at the beginning of the COVID-19 pandemic. But very rarely is alcohol discussed as being a part of […]
There is a recognizable need for improved treatment for substance use disorder in the United States. Drug overdose deaths are at an all-time high and standardization of the delivery and coverage for addiction treatment can be hard to find. Unfortunately, as it stands, addiction treatment and reimbursement practices can vary greatly from state to state, […]
The COVID-19 pandemic has presented challenges and opportunities for substance disorder treatment. IRETA and Vital Strategies are studying effects of OTP rule changes.
The National Institutes of Health (NIH) released a study that shows a combination of two medications, injectable naltrexone and oral bupropion, is safe and effective in treating methamphetamine use disorder.
I don’t believe that we can truly understand what those teachers lecturing about clinician burnout means until we’re “in the trenches” of this field. Let’s talk about compassion fatigue.
IRETA has hosted medical students in Pittsburgh for the Scaife Medical Student Fellowship in Substance Use Disorders. The fellowship offers medical students, typically between their first and second years of medical school, an intensive learning experience about substance use, addiction, and addiction treatment.